Literature DB >> 32355645

Predicting clinically significant prostate cancer from quantitative image features including compressed sensing radial MRI of prostate perfusion using machine learning: comparison with PI-RADS v2 assessment scores.

David Jean Winkel1, Hanns-Christian Breit1, Bibo Shi2, Daniel T Boll1, Hans-Helge Seifert3, Christian Wetterauer3.   

Abstract

BACKGROUND: To investigate if supervised machine learning (ML) classifiers would be able to predict clinically significant cancer (sPC) from a set of quantitative image-features and to compare these results with established PI-RADS v2 assessment scores.
METHODS: We retrospectively included 201, histopathologically-proven, peripheral zone (PZ) prostate cancer lesions. Gleason scores ≤3+3 were considered as clinically insignificant (inPC) and Gleason scores ≥3+4 as sPC and were encoded in a binary fashion, serving as ground-truth. MRI was performed at 3T with high spatiotemporal resolution DCE using Golden-angle RAdial SParse (GRASP) MRI. Perfusion maps (Ktrans, Kep, Ve), apparent diffusion coefficient (ADC), and absolute T2-signal intensities (SI) were determined in all lesions and served as input parameters for four supervised ML models: Gradient Boosting Machines (GBM), Neural Networks (NNet), Random Forest (RF) and Support Vector Machines (SVM). ML results and PI-RADS scores were compared with the ground-truth. Next ROC-curves and AUC values were calculated.
RESULTS: All ML models outperformed PI-RADS v2 assessment scores in the prediction of sPC (RF, GBM, NNet and SVM vs. PI-RADS: AUC 0.899, 0.864, 0.884 and 0.874 vs. 0.595, all P<0.001).
CONCLUSIONS: Using quantitative imaging parameters as input, supervised ML models outperformed PI-RADS v2 assessment scores in the prediction of sPC. These results indicate that quantitative imagining parameters contain relevant information for the prediction of sPC from image features. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Prostatic neoplasms; magnetic resonance imaging (MRI); supervised machine learning

Year:  2020        PMID: 32355645      PMCID: PMC7188610          DOI: 10.21037/qims.2020.03.08

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  47 in total

1.  An optimal radial profile order based on the Golden Ratio for time-resolved MRI.

Authors:  Stefanie Winkelmann; Tobias Schaeffter; Thomas Koehler; Holger Eggers; Olaf Doessel
Journal:  IEEE Trans Med Imaging       Date:  2007-01       Impact factor: 10.048

2.  Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence.

Authors:  Lutz Lüdemann; Daniel Prochnow; Torsten Rohlfing; Tobias Franiel; Carsten Warmuth; Matthias Taupitz; Hagen Rehbein; Dirk Beyersdorff
Journal:  Ann Biomed Eng       Date:  2009-01-24       Impact factor: 3.934

3.  A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis.

Authors:  Nikolaos Dikaios; David Atkinson; Chiara Tudisca; Pierpaolo Purpura; Martin Forster; Hashim Ahmed; Timothy Beale; Mark Emberton; Shonit Punwani
Journal:  Comput Med Imaging Graph       Date:  2017-02-05       Impact factor: 4.790

4.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Authors:  Jeffrey C Weinreb; Jelle O Barentsz; Peter L Choyke; Francois Cornud; Masoom A Haider; Katarzyna J Macura; Daniel Margolis; Mitchell D Schnall; Faina Shtern; Clare M Tempany; Harriet C Thoeny; Sadna Verma
Journal:  Eur Urol       Date:  2015-10-01       Impact factor: 20.096

5.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Authors:  Matthew D Greer; Joanna H Shih; Nathan Lay; Tristan Barrett; Leonardo Kayat Bittencourt; Samuel Borofsky; Ismail M Kabakus; Yan Mee Law; Jamie Marko; Haytham Shebel; Francesca V Mertan; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronald M Summers; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2017-07-19       Impact factor: 11.105

6.  Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.

Authors:  Sung Il Jung; Olivio F Donati; Hebert A Vargas; Debra Goldman; Hedvig Hricak; Oguz Akin
Journal:  Radiology       Date:  2013-07-22       Impact factor: 11.105

7.  Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.

Authors:  Daniel N Costa; B Nicolas Bloch; David F Yao; Martin G Sanda; Long Ngo; Elizabeth M Genega; Ivan Pedrosa; William C DeWolf; Neil M Rofsky
Journal:  Magn Reson Imaging       Date:  2013-04-18       Impact factor: 2.546

8.  Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study.

Authors:  Lorelei A Mucci; Anna Powolny; Edward Giovannucci; Zhiming Liao; Stacey A Kenfield; Rulong Shen; Meir J Stampfer; Steven K Clinton
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

9.  Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI.

Authors:  Li Feng; Robert Grimm; Kai Tobias Block; Hersh Chandarana; Sungheon Kim; Jian Xu; Leon Axel; Daniel K Sodickson; Ricardo Otazo
Journal:  Magn Reson Med       Date:  2013-10-18       Impact factor: 4.668

10.  SimpleITK Image-Analysis Notebooks: a Collaborative Environment for Education and Reproducible Research.

Authors:  Ziv Yaniv; Bradley C Lowekamp; Hans J Johnson; Richard Beare
Journal:  J Digit Imaging       Date:  2018-06       Impact factor: 4.056

View more
  7 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer.

Authors:  Hyungin Park; Seung Ho Kim; Joo Yeon Kim
Journal:  Quant Imaging Med Surg       Date:  2022-01

2.  Semi-automatic quantitative analysis of the pelvic bony structures on apparent diffusion coefficient maps based on deep learning: establishment of reference ranges.

Authors:  Xiang Liu; Chao Han; Ziying Lin; Zhaonan Sun; Yaofeng Zhang; Xiangpeng Wang; Xiaodong Zhang; Xiaoying Wang
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Development and validation of a nomogram based on multiparametric magnetic resonance imaging and elastography-derived data for the stratification of patients with prostate cancer.

Authors:  Zhimin Ding; Di Song; Huaiyu Wu; Hongtian Tian; Xiuqin Ye; Weiyu Liang; Jinfeng Xu; Fajin Dong
Journal:  Quant Imaging Med Surg       Date:  2021-07

Review 4.  Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML).

Authors:  Rima Hajjo; Dima A Sabbah; Sanaa K Bardaweel; Alexander Tropsha
Journal:  Diagnostics (Basel)       Date:  2021-04-21

Review 5.  Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review.

Authors:  Michael Roberts; Leonardo Rundo; Nikita Sushentsev; Nadia Moreira Da Silva; Michael Yeung; Tristan Barrett; Evis Sala
Journal:  Insights Imaging       Date:  2022-03-28

6.  Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning.

Authors:  Lorraine Abel; Jakob Wasserthal; Thomas Weikert; Alexander W Sauter; Ivan Nesic; Marko Obradovic; Shan Yang; Sebastian Manneck; Carl Glessgen; Johanna M Ospel; Bram Stieltjes; Daniel T Boll; Björn Friebe
Journal:  Diagnostics (Basel)       Date:  2021-05-19

7.  Prediction of Pathological Upgrading at Radical Prostatectomy in Prostate Cancer Eligible for Active Surveillance: A Texture Features and Machine Learning-Based Analysis of Apparent Diffusion Coefficient Maps.

Authors:  Jinke Xie; Basen Li; Xiangde Min; Peipei Zhang; Chanyuan Fan; Qiubai Li; Liang Wang
Journal:  Front Oncol       Date:  2021-02-04       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.